BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31678832)

  • 21. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact.
    Rena O; Boldorini R; Papalia E; Turello D; Massera F; Davoli F; Roncon A; Baietto G; Casadio C
    Ann Thorac Surg; 2014 Mar; 97(3):987-92. PubMed ID: 24480258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery.
    Tsitsias T; Okiror L; Veres L; King J; Harrison-Phipps K; Routledge T; Pilling J; Bille A
    Lung Cancer; 2021 Jan; 151():84-90. PubMed ID: 33250210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer.
    Fukui T; Kato K; Okasaka T; Kawaguchi K; Fukumoto K; Nakamura S; Hakiri S; Ozeki N; Yokoi K
    Gen Thorac Cardiovasc Surg; 2017 Nov; 65(11):640-645. PubMed ID: 28866794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
    Matsuoka K; Sumitomo S; Misaki N
    J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Small Cell Lung Cancer With N1 Involvement or Skip Metastases Presents the Same Survival Outcome: Results From a Multicentric Study.
    Chiappetta M; Sassorossi C; Lococo F; Sperduti I; Mucilli F; Lyberis P; Ratto G; Spaggiari L; Gallina F; Facciolo F; Margaritora S
    Clin Lung Cancer; 2023 Nov; 24(7):e275-e281. PubMed ID: 37481338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer.
    Ruiter J; de Langen A; Monkhorst K; Veenhof A; Klomp H; Smit J; Smit E; Damhuis R; Hartemink K
    Acta Chir Belg; 2024 Feb; ():1-9. PubMed ID: 38404182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of the number of involved lymph node stations in patients with completely resected non-small cell lung cancer: a proposal for future revisions of the N classification.
    Kojima H; Terada Y; Yasuura Y; Konno H; Mizuno T; Isaka M; Funai K; Ohde Y
    Gen Thorac Cardiovasc Surg; 2020 Nov; 68(11):1298-1304. PubMed ID: 32449108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases.
    Yoshino I; Nakanishi R; Osaki T; Takenoyama M; Taga S; Hanagiri T; Yasumoto K
    Chest; 1999 Jul; 116(1):144-9. PubMed ID: 10424518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
    Liu K; Chen HL; You QS; Huang JF; Wang H
    Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
    Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
    Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of node involvement pattern in pN1 non-small cell lung cancer patients.
    Nakao M; Yoshida J; Ishii G; Kawase A; Maeda R; Aokage K; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2010 Oct; 5(10):1576-82. PubMed ID: 20802346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study.
    Zhai W; Duan F; Zheng Y; Yan Q; Dai S; Chen T; Chen J; Wang J
    World J Surg Oncol; 2020 Sep; 18(1):258. PubMed ID: 32998771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.